•
Dec 31, 2023

Surgery Partners Q4 2023 Earnings Report

Announced fourth quarter and full year 2023 results and set 2024 guidance.

Key Takeaways

Surgery Partners reported a 4.0% increase in revenue for the fourth quarter of 2023, reaching $735.4 million. Days adjusted same-facility revenues increased by 8.1%. The company's Adjusted EBITDA was $142.3 million, compared to $120.8 million for the same period last year.

Revenue increased 4.0% to $735.4 million in the fourth quarter 2023.

Days adjusted same-facility revenues increased 8.1% in the fourth quarter 2023.

Net loss attributable to common stockholders was $1.0 million for the fourth quarter 2023.

Adjusted EBITDA increased 17.8% to $142.3 million in the fourth quarter 2023.

Total Revenue
$735M
Previous year: $707M
+4.0%
EPS
$0.44
Previous year: $0.27
+63.0%
Days adjusted revenue growth
8.1%
Previous year: 10.7%
-24.3%
Cases
153.19K
Revenue per case
$4.8K
Previous year: $4.54K
+5.7%
Gross Profit
$163M
Previous year: $184M
-11.8%
Cash and Equivalents
$196M
Previous year: $283M
-30.8%
Free Cash Flow
$18.5M
Previous year: -$15.5M
-219.4%
Total Assets
$6.88B
Previous year: $6.68B
+2.9%

Surgery Partners

Surgery Partners

Forward Guidance

The Company projects 2024 revenues to be greater than $3.0 billion, projects 2024 Adjusted EBITDA to be greater than $495 million.